Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus

ABSTRACT Persistent, high-risk human papillomavirus (HPV) infection is the primary cause of cervical cancer. Neutralizing antibodies elicited by L1-only virus-like particles (VLPs) can block HPV infection; however, the lack of high-resolution structures has limited our understanding of the mode of v...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhihai Li, Daning Wang, Ying Gu, Shuo Song, Maozhou He, Jingjie Shi, Xinlin Liu, Shuangping Wei, Jinjin Li, Hai Yu, Qingbing Zheng, Xiaodong Yan, Timothy S. Baker, Jun Zhang, Jason S. McLellan, Shaowei Li, Ningshao Xia
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2017
Materias:
Acceso en línea:https://doaj.org/article/8f49676155a44406a4ecc5706e4f012c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8f49676155a44406a4ecc5706e4f012c
record_format dspace
spelling oai:doaj.org-article:8f49676155a44406a4ecc5706e4f012c2021-11-15T15:51:50ZCrystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus10.1128/mBio.00787-172150-7511https://doaj.org/article/8f49676155a44406a4ecc5706e4f012c2017-11-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00787-17https://doaj.org/toc/2150-7511ABSTRACT Persistent, high-risk human papillomavirus (HPV) infection is the primary cause of cervical cancer. Neutralizing antibodies elicited by L1-only virus-like particles (VLPs) can block HPV infection; however, the lack of high-resolution structures has limited our understanding of the mode of virus infection and the requirement for type specificity at the molecular level. Here, we describe two antibodies, A12A3 and 28F10, that specifically bind to and neutralize HPV58 and HPV59, respectively, through two distinct binding stoichiometries. We show that the epitopes of A12A3 are clustered in the DE loops of two adjacent HPV58 L1 monomers, whereas 28F10 recognizes the HPV59 FG loop of a single monomer. Via structure-based mutagenesis and analysis of antibody binding, we further identified the residues HPV58 D154, S168, and N170 and HPV59 M267, Q270, E273, Y276, K278, and R283, which play critical roles in virus infection. By substituting these strategic epitope residues into other HPV genotypes, we could then redirect the type-specific binding of the antibodies to these genotypes, thus highlighting the importance of these specific residues, HPV58 R161, S168, and N308 and HPV59 Q270, E273, and D281. Overall, our findings provide molecular insights into potential structural determinants of HPV required for infectivity and type specificity. IMPORTANCE High-risk human papillomaviruses (HPVs) are considered the major causative pathogens of cancers that affect epithelial mucosa, such as cervical cancer. However, because of the lack of high-resolution structural information on the sites of neutralization, we have yet to determine the precise mode of HPV infection and how different types of HPV cause infection. Our crystal structures in this study have uncovered discrete binding stoichiometries for two different antibodies. We show that one A12A3 Fab binds to the center of one HPV58 pentamer, whereas five 28F10 Fabs bind along the top fringe of one HPV59 pentamer. Furthermore, through targeted epitope analysis, we show that 6 to 7 discontinuous residues of the L1 major capsid protein of HPV are determinants, at least in part, for virus infection and type specificity. This knowledge will help us to unravel the process of HPV infection and can potentially be used to drive the development of therapeutics that target neutralization-sensitive sites.Zhihai LiDaning WangYing GuShuo SongMaozhou HeJingjie ShiXinlin LiuShuangping WeiJinjin LiHai YuQingbing ZhengXiaodong YanTimothy S. BakerJun ZhangJason S. McLellanShaowei LiNingshao XiaAmerican Society for Microbiologyarticlehuman papillomavirusinfectivityneutralizationstructuretype specificityMicrobiologyQR1-502ENmBio, Vol 8, Iss 5 (2017)
institution DOAJ
collection DOAJ
language EN
topic human papillomavirus
infectivity
neutralization
structure
type specificity
Microbiology
QR1-502
spellingShingle human papillomavirus
infectivity
neutralization
structure
type specificity
Microbiology
QR1-502
Zhihai Li
Daning Wang
Ying Gu
Shuo Song
Maozhou He
Jingjie Shi
Xinlin Liu
Shuangping Wei
Jinjin Li
Hai Yu
Qingbing Zheng
Xiaodong Yan
Timothy S. Baker
Jun Zhang
Jason S. McLellan
Shaowei Li
Ningshao Xia
Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
description ABSTRACT Persistent, high-risk human papillomavirus (HPV) infection is the primary cause of cervical cancer. Neutralizing antibodies elicited by L1-only virus-like particles (VLPs) can block HPV infection; however, the lack of high-resolution structures has limited our understanding of the mode of virus infection and the requirement for type specificity at the molecular level. Here, we describe two antibodies, A12A3 and 28F10, that specifically bind to and neutralize HPV58 and HPV59, respectively, through two distinct binding stoichiometries. We show that the epitopes of A12A3 are clustered in the DE loops of two adjacent HPV58 L1 monomers, whereas 28F10 recognizes the HPV59 FG loop of a single monomer. Via structure-based mutagenesis and analysis of antibody binding, we further identified the residues HPV58 D154, S168, and N170 and HPV59 M267, Q270, E273, Y276, K278, and R283, which play critical roles in virus infection. By substituting these strategic epitope residues into other HPV genotypes, we could then redirect the type-specific binding of the antibodies to these genotypes, thus highlighting the importance of these specific residues, HPV58 R161, S168, and N308 and HPV59 Q270, E273, and D281. Overall, our findings provide molecular insights into potential structural determinants of HPV required for infectivity and type specificity. IMPORTANCE High-risk human papillomaviruses (HPVs) are considered the major causative pathogens of cancers that affect epithelial mucosa, such as cervical cancer. However, because of the lack of high-resolution structural information on the sites of neutralization, we have yet to determine the precise mode of HPV infection and how different types of HPV cause infection. Our crystal structures in this study have uncovered discrete binding stoichiometries for two different antibodies. We show that one A12A3 Fab binds to the center of one HPV58 pentamer, whereas five 28F10 Fabs bind along the top fringe of one HPV59 pentamer. Furthermore, through targeted epitope analysis, we show that 6 to 7 discontinuous residues of the L1 major capsid protein of HPV are determinants, at least in part, for virus infection and type specificity. This knowledge will help us to unravel the process of HPV infection and can potentially be used to drive the development of therapeutics that target neutralization-sensitive sites.
format article
author Zhihai Li
Daning Wang
Ying Gu
Shuo Song
Maozhou He
Jingjie Shi
Xinlin Liu
Shuangping Wei
Jinjin Li
Hai Yu
Qingbing Zheng
Xiaodong Yan
Timothy S. Baker
Jun Zhang
Jason S. McLellan
Shaowei Li
Ningshao Xia
author_facet Zhihai Li
Daning Wang
Ying Gu
Shuo Song
Maozhou He
Jingjie Shi
Xinlin Liu
Shuangping Wei
Jinjin Li
Hai Yu
Qingbing Zheng
Xiaodong Yan
Timothy S. Baker
Jun Zhang
Jason S. McLellan
Shaowei Li
Ningshao Xia
author_sort Zhihai Li
title Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
title_short Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
title_full Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
title_fullStr Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
title_full_unstemmed Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
title_sort crystal structures of two immune complexes identify determinants for viral infectivity and type-specific neutralization of human papillomavirus
publisher American Society for Microbiology
publishDate 2017
url https://doaj.org/article/8f49676155a44406a4ecc5706e4f012c
work_keys_str_mv AT zhihaili crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT daningwang crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT yinggu crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT shuosong crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT maozhouhe crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT jingjieshi crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT xinlinliu crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT shuangpingwei crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT jinjinli crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT haiyu crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT qingbingzheng crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT xiaodongyan crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT timothysbaker crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT junzhang crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT jasonsmclellan crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT shaoweili crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
AT ningshaoxia crystalstructuresoftwoimmunecomplexesidentifydeterminantsforviralinfectivityandtypespecificneutralizationofhumanpapillomavirus
_version_ 1718427352674861056